Hansoh Pharmaceutical Group Co Registered Shares HD -,00001

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

7.55%

Market Cap

21.81 Bil.

P/E Ratio

35.71

Dividend Yield

1.20 %

Earnings per Share

0.11 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE3.598 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 09:56:40 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW3.623.541
PREV. DAY'S PRICE3.587 (07/21)
CHANGE DAY BEFORE
+0.01
0.31 %
52 WEEK HIGH / LOW4.8 (01/15)3.077 (06/08)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.070.090.110.130.14
DIVIDENDS PER SHARE
0.030.040.050.050.06
DIVIDEND YIELD IN %
1.35 %1.95 %1.20 %--
DIVIDEND GROWTH IN %
107.12 %58.40 %23.17 %--
PRICE - EARNINGS RATIO
25.7821.6235.7129.4126.66
PRICE - BOOK RATIO
3.293.365.55--
PRICE - SALES RATIO
8.507.7313.24--
PRICE - CASH FLOW RATIO
23.5120.0325.03--
Further Key Figures

Master Data

WKN
A2PLRC
ISIN
KYG549581067
SYMBOL
3KY
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
HANSOH PHARMAC. HD-,00001
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Hong Kong Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
6.06 Bil.
MARKET CAPITALISATION
21.81 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
0.31 %
10.03 %
-14.27 %
-18.11 %
-7.55 %
158.06 %
10.71 %
-8.03 %
HIGH3.693.764.264.424.804.804.804.80
LOW3.473.113.083.083.081.111.113.08

Dividende

pro Aktie

Company profile

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, CNS diseases; metabolic and other diseases. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.